Interventional Cardiology

Interventional cardiology is a cardiology sub-specialty that deals specifically with systemic heart disease treatment based on the catheter.

A large number of operations can be performed on the heart via catheterization.

Specific treatments for interventional cardiology include angioplasty, percutaneous coronary operation, valvuloplasty, congenital heart defect reversal, percutaneous valve replacement, percutaneous valve repair, and coronary thrombectomy. The main benefits of using cardiology or radiology intervention approaches are the avoidance of wounds, pain, and lengthy post-operative recovery.

Interventional cardiologists in the U.S. and Canada require a minimum of seven years of postgraduate medical education and those who wish to specialize in multiple structural cardiac procedures need up to nine years of postgraduate medical education.


Cardiac catheterization | Angioplasty | Coronary stents | Embolic protection | Percutaneous valve repair | Balloon valvuloplasty|   Atherectomy

Market Statistics:

Due to COVID-19, the worldwide interventional cardiology market size is expected to be roughly $11.1 billion in 2020, down from over $14 billion in 2019. The global market is predicted to reach an astounding $16.2 billion in 2027.

Boston Scientific, Abbott, and Medtronic collectively held more than 40% of the global interventional cardiology market share. 

As a result of COVID19, the worldwide interventional cardiology market size declined by 20% from 2019 to 2020, reaching a valuation of $11.1 billion in 2020.